BioSpace News Archive

Through its OrbNet platform, Entos has already forged various partnerships with investors and leaders in the pharmaceuticals, materials, and chemicals industries.

Thermo Fisher Scientific has launched a new collaborative unit that aims to standardize the metabolomics community’s efforts as it engages in more large-scale cohort studies and clinical research.

In an interview with BioSpace, CEO Victoria Richon expressed her excitement about investor support and developing novel, first-in-class treatments.

According to the report, the global soft tissue market was valued at US$ 4.3 Mn in 2020 and is projected to expand at a CAGR of ~7% from 2021 to 2031.

According to the report, the global microarray scanners market was valued at US$ 700 Mn in 2019 and is projected to expand at a CAGR of ~7% from 2020 to 2030.

Histology and cytology comprises investigating structure of tissues and cells respectively typically at the microscopic level, and the study includes both animals and plants.

Dyslipidemia, a key risk factor for cardiovascular disease, poses high health burden to the developed world, thus, propelling the need for effective therapies that are well tolerated.

According to the report, the global direct-to-consumer laboratory testing market was valued at US$ 2.4 Bn in 2020.

The antimicrobial susceptibility test market survey offers insights into chief growth drivers and restrains impacting the overall growth trajectory.

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, commented on the recently released Centers for Medicare and Medicaid Services Calendar Year 2022 Medicare Physician Fee Schedule Proposed Rule.